Last reviewed · How we verify
EPOETIN DELTA
EPOETIN DELTA is a drug. It is currently FDA-approved (first approved 2002).
Epoetin delta, also known as Dynepo, is a protein-based erythropoietin receptor agonist used to treat conditions such as anemia and chronic kidney diseases. It works by stimulating the erythropoietin receptor to increase red blood cell production.
At a glance
| Generic name | EPOETIN DELTA |
|---|---|
| Modality | Recombinant protein |
| Phase | FDA-approved |
| First approval | 2002 |
Approved indications
Common side effects
Key clinical trials
- Identifying Biological Markers for Altitude Exposure and Use of Recombinant Human Erythropoietin (rHuEPO) (NA)
- Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.
- Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants (PHASE3)
- Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants (PHASE3)
- Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044 (PHASE3)
- Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis (PHASE3)
- Dynepo Long-Term Safety Study (PHASE4)
- DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EPOETIN DELTA CI brief — competitive landscape report
- EPOETIN DELTA updates RSS · CI watch RSS
Frequently asked questions about EPOETIN DELTA
What is EPOETIN DELTA?
When was EPOETIN DELTA approved?
What development phase is EPOETIN DELTA in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing